Vaxart Q4 2023 GAAP EPS $(0.12) Beats $(0.14) Estimate, Sales $3.245M Beat $1.250M Estimate
Vaxart Q4 2023 GAAP EPS $(0.12) Beats $(0.14) Estimate, Sales $3.245M Beat $1.250M Estimate
Vaxart2023年第四季度GAAP每股收益（0.12）超過預期（0.14）美元，銷售額324.5萬美元超過12.5億美元的預期
Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 33.33 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $3.245 million which beat the analyst consensus estimate of $1.250 million by 159.60 percent. This is a 14.65K percent increase over sales of $22.000 thousand the same period last year.
Vaxart（納斯達克股票代碼：VXRT）公佈的季度虧損爲每股0.12美元，比分析師普遍預期的0.14美元（0.14美元）高出14.29％。這比去年同期每股虧損0.18美元（0.18美元）增長了33.33％。該公司公佈的季度銷售額爲324.5萬美元，比分析師普遍預期的12.5億美元高出159.60％。這比去年同期的22,000美元的銷售額增長了14.65萬個百分點。